CA2160052A1 - Agent de visualisation pour diagnostics - Google Patents

Agent de visualisation pour diagnostics

Info

Publication number
CA2160052A1
CA2160052A1 CA002160052A CA2160052A CA2160052A1 CA 2160052 A1 CA2160052 A1 CA 2160052A1 CA 002160052 A CA002160052 A CA 002160052A CA 2160052 A CA2160052 A CA 2160052A CA 2160052 A1 CA2160052 A1 CA 2160052A1
Authority
CA
Canada
Prior art keywords
diagnostic imaging
imaging agent
cyclodextrin
do3ma
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002160052A
Other languages
English (en)
Inventor
Yuji Hashiguchi
Kan Kubomura
Toshihiro Kamada
Shigemi Seri
Kumiko Iwai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nihon Medi Physics Co Ltd
Original Assignee
Nihon Medi Physics Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon Medi Physics Co Ltd filed Critical Nihon Medi Physics Co Ltd
Priority to CA002160052A priority Critical patent/CA2160052A1/fr
Publication of CA2160052A1 publication Critical patent/CA2160052A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/103—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being acyclic, e.g. DTPA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/106—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being cyclic, e.g. DOTA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/12—Macromolecular compounds
    • A61K49/126—Linear polymers, e.g. dextran, inulin, PEG
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Radiology & Medical Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Nanotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA002160052A 1995-10-06 1995-10-06 Agent de visualisation pour diagnostics Abandoned CA2160052A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002160052A CA2160052A1 (fr) 1995-10-06 1995-10-06 Agent de visualisation pour diagnostics

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002160052A CA2160052A1 (fr) 1995-10-06 1995-10-06 Agent de visualisation pour diagnostics

Publications (1)

Publication Number Publication Date
CA2160052A1 true CA2160052A1 (fr) 1997-04-07

Family

ID=4156721

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002160052A Abandoned CA2160052A1 (fr) 1995-10-06 1995-10-06 Agent de visualisation pour diagnostics

Country Status (1)

Country Link
CA (1) CA2160052A1 (fr)

Similar Documents

Publication Publication Date Title
US5271924A (en) Low molecular weight polysaccharide complexes for nuclear magnetic resonance imaging
AU579411B2 (en) Gadolinium chelates as nmr contrast agents
EP0236411B1 (fr) Agent de contraste pour la mise en image par resonance magnetique nucleaire
KR20100120971A (ko) 가돌리늄 착물, 그 제조방법, 및 그것을 포함하는 ｍｒｉ 조영제
KR100343313B1 (ko) 진단용조영제
EP0766968B1 (fr) Agent pour l'imagerie diagnostique
US5271929A (en) Nuclear magnetic resonance imaging agent comprising a di-aldehyde complex
HUT59115A (en) Process for producing 10-(2'-hydroxy-3'-alkoxy)-1,4,7-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecanes
NZ236267A (en) 10-(2'-hydroxy-3'-polyoxaalkyl)-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane
CA2160052A1 (fr) Agent de visualisation pour diagnostics
US11717580B2 (en) Cyclodextrin-linked polyvalent ligands for complexation of metal ions
JPH0812596A (ja) 画像診断用造影剤
US20040067201A1 (en) MRI image enhancement compositions
KR100368840B1 (ko) 진단용조영제
DE69519928T2 (de) Diagnostikum zur Bilderzeugung
KR100448100B1 (ko) 상자성 금속-프탈로시아닌 착화합물 및 이를 이용한영상화용 조영제
JP3170192B2 (ja) 画像診断用造影剤

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20011009